Rizzardini, G., Overton, E. T., Orkin, C., Swindells, S., Arasteh, K., Górgolas Hernández-Mora, M., . . . Margolis, D. A. (2020). Long-Acting Injectable Cabotegravir + Rilpivirine for HIV Maintenance Therapy: Week 48 Pooled Analysis of Phase 3 ATLAS and FLAIR Trials. J Acquir Immune Defic Syndr.
Citación estilo ChicagoRizzardini, Giuliano, et al. "Long-Acting Injectable Cabotegravir + Rilpivirine for HIV Maintenance Therapy: Week 48 Pooled Analysis of Phase 3 ATLAS and FLAIR Trials." J Acquir Immune Defic Syndr 2020.
Cita MLARizzardini, Giuliano, et al. "Long-Acting Injectable Cabotegravir + Rilpivirine for HIV Maintenance Therapy: Week 48 Pooled Analysis of Phase 3 ATLAS and FLAIR Trials." J Acquir Immune Defic Syndr 2020.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.